Inflammatory Breast Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033 thelansis.com

Inflammatory breast cancer is a rapidly progressing and aggressive form of breast cancer characterized by the infiltration of cancer cells into the skin and lymph vessels of the breast. Unlike many other breast cancers, it often lacks a distinct tumor or lump that can be palpated within the breast. Early symptoms of inflammatory breast cancer may manifest as persistent itching and a rash or small irritation resembling an insect bite. The affected breast typically becomes red, swollen, and warm, accompanied by the dilation of pores on the breast skin, which can give it a pitted appearance similar to an orange peel. Additionally, changes in the nipple, such as inversion, flattening, or dimpling, may occur. There are several established risk factors associated with inflammatory breast cancer. Reproductive factors play a significant role, with a higher risk observed in women who experience early menarche and give birth to their first child at a younger age. Inflammatory breast cancer is categorized into either stage 3B, 3C, or stage 4, each with distinct characteristics:
• Stage 3B involves the spread of cancer into nearby tissues, such as the skin of the breast and the underlying chest muscle, potentially extending to lymph nodes in the armpit.
• Stage 3C signifies the presence of cancer in lymph nodes located in the armpit or below the breastbone, either above or below the collarbone.
• Stage 4 indicates that the cancer has extended beyond the breast and nearby lymph nodes.
The minimum criteria for diagnosing inflammatory breast cancer include the following:
1. The rapid onset of symptoms, including redness (erythema), swelling (edema), a peau d’orange texture (ridged or pitted skin), and abnormal warmth in the breast, with or without a palpable lump.
2. The symptoms have been present for less than six months.
3. The redness (erythema) affects at least one-third of the breast.
4. Initial biopsy samples from the affected breast confirm the presence of invasive carcinoma.
Treatment for inflammatory breast cancer typically includes surgery, radiation therapy, chemotherapy, and hormone treatments.
• In the United States, there are an estimated 3.1 cases of inflammatory breast cancer per 100,000 women, which is more commonly diagnosed in women under 40.

Thelansis’s “Inflammatory Breast Cancer Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033″ covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Inflammatory Breast Cancer treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

KOLs insights of Inflammatory Breast Cancer across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Inflammatory Breast Cancer Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Inflammatory Breast Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033